Nicholas Goldner

Nicholas Goldner

Company: Resistance Bio

Job title: CEO & Co-Founder


Harnessing Cancer’s Adaptive Resistance Profiles in NSCLC 9:30 am

Developing a novel method and algorithm for picking up resistance mechanisms that can not be identified via current technologies Utilizing proprietary tissue culture technology termed the ResCu system to more accurately recapitulate the emergence of resistance seen in the clinic. The system captures the emergence of “crawlers” – resistant subpopulations and their frequency of occurrence…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.